CDE Considers Breakthrough Therapy Designation for Beijing Mabworks’ MIL162 and Amgen’s AMG 890
The Center for Drug Evaluation (CDE) website indicates that China-based Beijing Mabworks Biotech Co., Ltd’s...
Fujian Cosunter Pharmaceutical’s COVID-19 Drug GST-HG171 Meets Primary Endpoint in Phase II/III Study
China-based Fujian Cosunter Pharmaceutical Co., Ltd (SHE: 300436) has announced that the pivotal Phase II/III...
Boehringer Ingelheim’s Spevigo on Track for Priority Review for GPP Flare Prevention in China
Germany-based Boehringer Ingelheim’s (BI) interleukin-36 receptor (IL-36R)-targeted orphan drug, Spevigo (spesolimab), in subcutaneous injection form,...
Bio-Thera Solutions’ PD-1 Inhibitor BAT1308 Approved for Cervical Cancer Clinical Trials in China
Bio-Thera Solutions Ltd (SHA: 688177) has announced that its programmed death-1 (PD-1) inhibitor, BAT1308, has...
Pfizer to Establish Smart Medical Innovation Center in Hangzhou’s Qiantang District
US pharmaceutical giant Pfizer (NSE: PFIZER) has announced a plan to establish a smart medical...
Medivir AB Receives Chinese Patent Approval for Liver Cancer Treatment Fostroxacitabine Bralpamide
Sweden-based Medivir AB (FRA: MVR0) has announced the approval of a patent in China for...
Shanghai Cell Therapy Group Partners with Nantong Federation for Comprehensive Health Services Platform
Shanghai Cell Therapy Group has entered into a partnership with the Nantong Federation of Industry...
Huadong Medicine’s Subsidiary Perfect mRNA Biotechnology Partners with Yoltech Therapeutics
China-based Huadong Medicine Co., Ltd (SHE: 000963) subsidiary, Hangzhou Perfect mRNA Biotechnology Co., Ltd, has...
Merck Appoints Marc Horn as China Unit President, Succeeding Allan Gabor
Germany-based Merck (NYSE: MRK) has announced the appointment of Marc Horn as its China unit...
Sinocelltech Group Launches Biosimilar Version of AbbVie’s Humira in China
China-based Sinocelltech Group Ltd (SHA: 688520) has officially commercialized its biosimilar version of AbbVie’s (NYSE:...
Grand Pharmaceutical Initiates Phase II STARBURST Study for TLX250-CDx in Indication Expansion
China-based Grand Pharmaceutical Group Limited (HKG: 0512) has announced the first patient dosing in the...
Novlead Biotech Secures RMB 100 Million in Series B+ Financing for Nitric Oxide Therapy Innovations
Novlead Biotech, a specialist in nitric oxide gas detection and treatment based in Nanjing, has...
Guangdong Zhongsheng Pharmaceutical Plans to Raise RMB 600 Million via Private Placement
China-based Guangdong Zhongsheng Pharmaceutical Co., Ltd (SHE: 002317) is poised to raise RMB 600 million...
Shanghai Pharmaceuticals’ SPH3127 for Hypertension Gets MNPA Review Acceptance
China-based Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607) has announced that the National Medical Products...
United Imaging Healthcare Acquires Stake in Apactron for High-End Particle Therapy Technology
Shanghai-based United Imaging Healthcare (UIH, SHA: 688271) has announced an investment of RMB 45 million...
Sequanta Technologies Partners with DarkJade Sciences to Establish Organoid Bank and Glioma Project
Sequanta Technologies, a leading multi-omics research and clinical service provider based in Shanghai, has announced...
Insilico Medicine Partners with ShanghaiTech University for Tumor Drug R&D Advancement
China-based AI-powered drug discovery firm Insilico Medicine has struck a partnership with ShanghaiTech University’s iHuman...
WinHealth Pharma Receives NMPA Approval for Glycerol Phenylbutyrate for Urea Cycle Disorders
China-based Hong Kong WinHealth Pharma Group Ltd has announced receiving market approval from the National...
Nanjing Leads Biolabs Receives FDA IND Approval for LBL-033 Phase I/II Clinical Trial
China-based Nanjing Leads Biolabs Co., Ltd has revealed that it has received Investigational New Drug...
AstraZeneca Weighs Spinning Off China Business to Shield Against Geopolitical Tensions
According to a report from the UK newspaper The Financial Times (FT), AstraZeneca (AZ, NASDAQ:...